Learn about conventional, complementary, and integrative therapies.
Dealing with treatment side effects? Learn about evidence-based therapies to alleviate your symptoms.
Click the orange button to the right to learn more.
Skin Cancer: Need-to-Know – Skin cancer is the most common cancer diagnosed in the United States. While many cases are detected early and successfully treated, advanced or aggressive skin cancers can require complex therapies that produce both short- and long-term side effects. Patients frequently benefit from combining standard oncology treatments with evidence-based integrative therapies that reduce toxicity, improve quality of life, and may support treatment effectiveness.
If you or someone you love has been diagnosed with skin cancer, understanding the disease, treatment options, and supportive therapies can help you make informed decisions and improve outcomes.
This post explains the essentials of skin cancer and highlights evidence-based integrative therapies that may improve treatment tolerance, immune function, and survivorship.
Be sure to watch each of the videos about:
I am a long-term survivor of an incurable blood cancer called multiple myeloma. My research and experience with evidence-based non-conventional therapies is the reason why I have lived in complete remission since 1999. I have learned that the best way to manage aggressive cancers is to combine the best of conventional and evidence-based non-conventional therapies.
Good luck,
Skin cancer develops when abnormal skin cells grow uncontrollably, most commonly due to ultraviolet (UV) radiation exposure from sunlight or tanning beds. The three major types include:
UV radiation causes DNA damage in skin cells, which can lead to mutations that drive tumor growth. Genetic susceptibility, immune function, and environmental exposure all influence disease development.
• Skin cancer is the most common cancer worldwide
• Melanoma accounts for most skin cancer deaths
• Early-stage skin cancers are highly curable
• Incidence rates continue rising due to UV exposure and aging populations
Early detection dramatically improves survival outcomes.
• Excess ultraviolet (UV) exposure
• History of sunburns
• Fair skin, light eyes, or red/blond hair
• Tanning bed use
• Personal or family history of skin cancer
• Multiple or atypical moles
• Immunosuppression
• Older age
• Male gender (for melanoma mortality risk)
• Occupational sun exposure
• Genetic syndromes such as xeroderma pigmentosum
Early skin cancer often appears as changes in the skin.
Common warning signs include:
• New or changing mole
• Asymmetrical mole or lesion
• Irregular borders
• Color variation
• Diameter larger than 6 mm
• Non-healing sores
• Lesions that itch, bleed, or crust
Any suspicious skin lesion should be evaluated promptly.
Diagnosis may include:
• Skin examination using dermoscopy
• Skin biopsy
• Sentinel lymph node biopsy (melanoma)
• CT, MRI, or PET imaging
• Molecular and genomic tumor testing
Genetic testing is increasingly important because targeted therapies and immunotherapies now exist for several tumor mutations, especially melanoma.
Treatment depends on tumor type, stage, and molecular characteristics.
Most skin cancers are treated with:
Used when surgery is not possible or to reduce recurrence risk.
Common agents include:
These treatments are particularly important for melanoma and advanced SCC.
For tumors with specific mutations, such as BRAF-mutated melanoma.
Less commonly used today but it may be used in advanced disease.
Patients may experience:
• Scarring
• Nerve damage
• Cosmetic changes
• Lymphedema (advanced melanoma surgery)
• Skin irritation
• Fatigue
• Fibrosis
• Pigment changes
• Autoimmune reactions
• Skin rashes
• Fatigue
• Thyroid dysfunction
• Gastrointestinal inflammation
• Fever
• Fatigue
• Joint pain
• Photosensitivity
Integrative oncology combines conventional cancer treatments with evidence-based complementary therapies designed to improve treatment response, reduce side effects, and improve long-term survivorship.
Integrative therapies are not replacements for conventional treatment. Research suggests they may enhance treatment tolerance, immune function, and overall patient outcomes when used safely under medical supervision.
High-dose intravenous vitamin C may:
Pharmacologic vitamin C generates hydrogen peroxide in tumor microenvironments, which may preferentially damage cancer cells while sparing healthy tissue.
IV vitamin C should:
Emerging evidence suggests the gut microbiome plays a major role in cancer progression and treatment response.
Prehabilitation programs focus on improving physical fitness, nutrition, and emotional readiness prior to surgery or systemic therapy to optimize recovery and reduce complications.
Fasting strategies may support cancer therapy through metabolic and immune modulation.
Caloric restriction and fasting may:
Fasting must be individualized and medically supervised in cancer patients.
Metabolic therapy targets cancer cell energy pathways.
Melanoma and other skin cancers demonstrate metabolic flexibility and increased glycolytic activity. Metabolic therapies may help create environments less supportive of tumor growth.
Physical activity helps:
Exercise has been linked to improved survival outcomes in melanoma survivors.
Nutritional interventions focus on:
Certain nutrients support skin protection and repair from UV damage.
Certain supplements show potential benefit in improving immune response, reducing inflammation, and supporting treatment tolerance.
May reduce inflammation and improve treatment tolerance.
Vitamin D regulates immune function and may influence melanoma outcomes.
Demonstrates anti-inflammatory and tumor-modulating properties.
Compounds such as turkey tail, reishi, and maitake may enhance immune response during cancer treatment.
Integrative survivorship care should focus on:
Skin cancer ranges from highly curable early-stage disease to aggressive metastatic cancers such as melanoma. Evidence-based integrative therapies that support immune function, metabolism, and inflammation control may help reduce treatment toxicity and support outcomes.
Research continues to explore promising approaches, including:
Every skin cancer patient is unique. Integrative oncology offers additional tools that may improve quality of life and long-term survivorship when coordinated with standard medical care.
Patients should always discuss complementary therapies with their oncology team before beginning any new treatment strategy.
Skin Cancer: Need-to-Know Skin Cancer: Need-to-Know Skin Cancer: Need-to-Know Skin Cancer: Need-to-Know